| |
| |
|
| Insider
Information: |
Gionco David |
| Relationship: |
Chief Accounting Officer |
| City: |
East Brunswick |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
35,764 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
35,764 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 688.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Savient Pharmaceuticals Inc |
SVNTQ |
Chief Accounting Officer |
2013-10-15 |
35,764 |
|
0 |
Premium* |
|
|
Stemline Therapeutics Inc |
STML |
Chief Accounting Officer |
2020-06-10 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STML |
Stemline Therapeutics Inc |
Chief Accounting OfficerOffice |
• – – |
2014-01-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,000 |
|
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2015-01-20 |
4 |
S |
$14.22 |
$47,082 |
D/D |
(3,311) |
26,689 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
11,569 |
38,258 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2016-01-19 |
4 |
S |
$4.82 |
$15,284 |
D/D |
(3,171) |
35,290 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2016-01-20 |
4 |
S |
$4.69 |
$216 |
D/D |
(46) |
35,244 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
72,023 |
107,267 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2016-03-08 |
4 |
S |
$5.32 |
$6,107 |
D/D |
(1,148) |
106,467 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2017-01-19 |
4 |
S |
$11.46 |
$41,176 |
D/D |
(3,593) |
103,392 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2017-02-27 |
4 |
S |
$6.97 |
$24,395 |
D/D |
(3,500) |
99,892 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2017-02-28 |
4 |
S |
$7.01 |
$20,932 |
D/D |
(2,986) |
96,906 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2017-03-07 |
4 |
S |
$8.13 |
$9,073 |
D/D |
(1,116) |
95,914 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2017-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
70,299 |
166,213 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2018-01-17 |
4 |
S |
$13.43 |
$57,078 |
D/D |
(4,250) |
162,538 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2018-03-07 |
4 |
S |
$16.56 |
$23,399 |
D/D |
(1,413) |
152,275 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2018-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
37,592 |
189,867 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2018-03-12 |
4 |
S |
$17.20 |
$159,595 |
D/D |
(9,183) |
180,684 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2018-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
170,345 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
78,559 |
248,904 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2019-02-25 |
4 |
S |
$12.03 |
$103,013 |
D/D |
(8,563) |
240,341 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2019-03-07 |
4 |
S |
$11.32 |
$15,633 |
D/D |
(1,381) |
238,960 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2019-03-11 |
4 |
S |
$11.11 |
$149,896 |
D/D |
(13,492) |
225,468 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2019-03-12 |
4 |
S |
$11.05 |
$5,857 |
D/D |
(530) |
224,938 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
239,938 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2019-12-23 |
4 |
S |
$10.58 |
$4,454 |
D/D |
(421) |
239,517 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Accounting Officer |
• – – |
2019-12-24 |
4 |
S |
$10.97 |
$26,196 |
D/D |
(2,388) |
237,129 |
0 |
- |
|
58 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
